Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20141
20161
20202
20211
20221
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
AstraZeneca1
Basilea Pharmaceutica1
BioNTech SE1
Bold Therapeutics, Inc.1
EMD Serono Research & Development Institute, Inc.1
FeRx1
Johannes Gutenberg University Mainz1
Merus B.V.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms13
Colorectal Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Esophageal Neoplasms4
Pancreatic Neoplasms4
Cholangiocarcinoma3
Sarcoma3
Biliary Tract Neoplasms2
Breast Neoplasms2
Endometrial Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.